| Distinct plasma immune signatures in ME/CFS are present early in the course of illness M Hornig, JG Montoya, NG Klimas, S Levine, D Felsenstein, L Bateman, ... Science advances 1 (1), e1400121, 2015 | 263 | 2015 |
| Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations AH Mandarano, J Maya, L Giloteaux, DL Peterson, M Maynard, ... The Journal of clinical investigation 130 (3), 1491-1505, 2020 | 102 | 2020 |
| Multi-site clinical assessment of myalgic encephalomyelitis/chronic fatigue syndrome (MCAM): design and implementation of a prospective/retrospective rolling cohort study ER Unger, JMS Lin, H Tian, BH Natelson, G Lange, D Vu, M Blate, ... American journal of epidemiology 185 (8), 617-626, 2017 | 40 | 2017 |
| Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations M Hornig, CG Gottschalk, ML Eddy, X Che, JE Ukaigwe, DL Peterson, ... Translational psychiatry 7 (4), e1080-e1080, 2017 | 37 | 2017 |
| Gemfibrozil protects dopaminergic neurons in a mouse model of Parkinson's disease via PPARα-dependent astrocytic GDNF pathway CG Gottschalk, M Jana, A Roy, DR Patel, K Pahan Journal of Neuroscience 41 (10), 2287-2300, 2021 | 23 | 2021 |
| Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome NG Klimas, G Ironson, A Carter, E Balbin, L Bateman, D Felsenstein, ... Fatigue: Biomedicine, Health & Behavior 3 (2), 75-96, 2015 | 17 | 2015 |
| Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases CG Gottschalk, D Peterson, J Armstrong, K Knox, A Roy Infectious agents and cancer 18 (1), 7, 2023 | 12 | 2023 |
| Altered fatty acid oxidation in lymphocyte populations of myalgic encephalomyelitis/chronic fatigue syndrome J Maya, SM Leddy, CG Gottschalk, DL Peterson, MR Hanson International Journal of Molecular Sciences 24 (3), 2010, 2023 | 10 | 2023 |
| Peptides for Covid-19 prevention and treatment A Roy, CG Gottschalk US Patent 11,078,242, 2021 | 9 | 2021 |
| Activation of peroxisome proliferator-activated receptor-α increases the expression of nuclear receptor related 1 protein (Nurr1) in dopaminergic neurons CG Gottschalk, A Roy, M Jana, M Kundu, K Pahan Molecular neurobiology 56, 7872-7887, 2019 | 8 | 2019 |
| Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv. 2015; 1 (1): e1400121 M Hornig, JG Montoya, NG Klimas, S Levine, D Felsenstein, L Bateman, ... | 3 | |
| Detection of Elevated Level of Tetrahydrobiopterin in Serum Samples of ME/CFS Patients with Orthostatic Intolerance: A Pilot Study CG Gottschalk, R Whelan, D Peterson, A Roy International Journal of Molecular Sciences 24 (10), 8713, 2023 | 1 | 2023 |
| Heterogeneity in Measures of Illness among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Not Explained by Clinical Practice: A Study in Seven US Specialty … ER Unger, JMS Lin, Y Chen, ME Cornelius, B Helton, AN Issa, J Bertolli, ... Journal of Clinical Medicine 13 (5), 1369, 2024 | | 2024 |
| Augmentation of Anaerobic Pentose Phosphate Pathway Dysregulates Tetrahydrobiopterin Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Patients with … S Bulbule, CG Gottschalk, ME Drosen, D Peterson, LA Arnold, A Roy | | 2023 |
| Peptides for Covid-19 Prevention and Treatment A Roy, CG Gottschalk US Patent App. 17/393,328, 2022 | | 2022 |
| Molecular evidence of autophagy impairment as serum level of ATG13 is elevated in patients with myalgic encephalomyelitis and chronic fatigue syndrome: two independent case … A Roy, CG Gottschalk, D Peterson, K Knox, M Maynard, RJ Whelan | | 2021 |
| The Neuroprotective Capabilities of Gemfibrozil in Animal Models of Parkinson’s Disease and Related Disorders CG Gottschalk Rush University, 2020 | | 2020 |
| Gemfibrozil, a lipid lowering drug, increases Nurr1 in dopaminergic neurons via PPAR alpha C Gottschalk, A Roy, K Pahan JOURNAL OF NEUROIMMUNE PHARMACOLOGY 13, S31-S31, 2018 | | 2018 |
W. Ian Lipkincolumbia universityVerified email at columbia.edu
